Search Results

Filter
  • 1-10 of  26,064 results for ""CLINICAL trials""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis.

  • Authors : Shih WJ; Rutgers University School of Public Health, Piscataway, NJ, USA. .; Yao C

Subjects: Clinical Trials, Phase III as Topic* ; Data Accuracy* ; Randomized Controlled Trials as Topic*

  • Source: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2020 Sep; Vol. 54 (5), pp. 1236-1255. Date of Electronic Publication: 2020 May 16.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Characteristics of clinical trials of new oncology drugs approved in China.

  • Authors : Yang J; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao Special Administrative Region, China.; Yang J

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use; Humans ; China

  • Source: Cancer [Cancer] 2024 Mar 01; Vol. 130 (5), pp. 671-682. Date of Electronic Publication: 2023 Nov 20.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

×
Academic Journal

Uptake of core outcome sets by clinical trialists in China: a protocol.

  • Authors : Qiu R; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.; University of Liverpool, Liverpool, England, UK.

Subjects: Outcome Assessment, Health Care*/Outcome Assessment, Health Care*/Outcome Assessment, Health Care*/methods ; Research Design*; China

  • Source: F1000Research [F1000Res] 2024 Mar 28; Vol. 12, pp. 1030. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2023).Publisher: F1000 Research Ltd Country of Publication: England NLM ID: 101594320 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Risk Factors for Postoperative Cognitive Decline After Orthopedic Surgery in Elderly Chinese Patients: A Retrospective Cohort Study.

Subjects: Anesthetics* ; Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/epidemiology ; Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/etiology

  • Source: Clinical interventions in aging [Clin Interv Aging] 2024 Mar 19; Vol. 19, pp. 491-502. Date of Electronic Publication: 2024 Mar 19 (Print Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101273480 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Periodical

Bioartificial liver system approved for clinical trials in China.

Subjects: End Stage Liver Disease* ; Liver, Artificial*; Humans

  • Source: Artificial organs [Artif Organs] 2024 Mar; Vol. 48 (3), pp. 208-209. Date of Electronic Publication: 2023 Dec 16.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7802778 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of an artificial intelligence-based clinical trial matching system in Chinese patients with hepatocellular carcinoma: a retrospective study.

  • Authors : Wang K; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, No. 1838, North Guangzhou Avenue, Baiyun District, Guangzhou, China.; Cui H

Subjects: Artificial Intelligence* ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnosis ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy

  • Source: BMC cancer [BMC Cancer] 2024 Feb 22; Vol. 24 (1), pp. 246. Date of Electronic Publication: 2024 Feb 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Fruquintinib plus oxaliplatin combined with S-1 (SOX) as neoadjuvant therapy for locally advanced gastric cancer (GC) or gastro-oesophageal junction adenocarcinoma (GEJ): a multicentre, phase II, single-arm, open-label clinical trial (FRUTINEOGA) protocol.

  • Authors : Wu L; Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Yan H

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/surgery ; Benzofurans* Adenocarcinoma Of Esophagus

  • Source: BMJ open [BMJ Open] 2024 Feb 10; Vol. 14 (2), pp. e075696. Date of Electronic Publication: 2024 Feb 10.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C).

  • Authors : Zhang H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.

Subjects: Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/pathology ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/pathology

  • Source: BMJ open [BMJ Open] 2024 Feb 02; Vol. 14 (2), pp. e079442. Date of Electronic Publication: 2024 Feb 02.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution.

  • Authors : Huang H; Clinical Trial Office, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, 17 South Panjiayuan Lane, Chaoyang District, Beijing, 100021, People's Republic of China.; Tang Y

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/epidemiology

  • Source: BMC geriatrics [BMC Geriatr] 2023 Mar 30; Vol. 23 (1), pp. 199. Date of Electronic Publication: 2023 Mar 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100968548 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2318

Record details

×
Academic Journal

Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease.

  • Authors : Webster KA; Vascular Biology Institute, University of Miami, Miami, FL 33146, USA.; Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA.

Subjects: Biological Therapy* ; Peripheral Arterial Disease*/Peripheral Arterial Disease*/Peripheral Arterial Disease*/complications ; Peripheral Arterial Disease*/Peripheral Arterial Disease*/Peripheral Arterial Disease*/drug therapy

  • Source: Genes [Genes (Basel)] 2024 Jan 22; Vol. 15 (1). Date of Electronic Publication: 2024 Jan 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425

Record details

×
  • 1-10 of  26,064 results for ""CLINICAL trials""